West Pharmaceutical Services | WST - Equity Capital And Reserves


West Pharmaceutical Services reported $2.99B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Align Technology USD 4.23B 83.03M Jun/2026
Baxter International USD 6.21B 163M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Cerus USD 64.22M 2.76M Dec/2025
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
Dentsply International USD 1.35B 33M Jun/2026
Haemonetics USD 837.1M 40.78M Jun/2026
ICU Medical USD 2.15B 39.92M Jun/2026
Insulet USD 1.42B 119.6M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.68B 53.08M Jun/2026
Neogen USD 2.09B 9.5M Mar/2026
OraSure Technologies USD 313.32M 27.5M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
Repligen USD 2.11B 6.57M Jun/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 4.8B 169M Jun/2026
STAAR Surgical USD 352.37M 8.18M Mar/2026
Terumo JPY 1.58T 62.18B Mar/2026
Utah Medical Products USD 120.37M 1.1M Mar/2026
West Pharmaceutical Services USD 2.99B 200K Jun/2026